
This content was machine translated.
About Mermaid Bio
Today’s antibody drugs reach only 10% of their potential targets, leaving many patients without treatment options. Mermaid Bio is pioneering the development of intrabody therapies to give patients new hope. Using cutting-edge biotechnology, the company develops antibodies for intracellular targets (intrabodies) and treats diseases from within. Mermaid Bio is developing the next generation of antibody drugs to treat currently untreated patients in the future.
More like this
